KR20220035882A - Biomarker for distinguishing cancer from benign tumors or nodules - Google Patents
Biomarker for distinguishing cancer from benign tumors or nodules Download PDFInfo
- Publication number
- KR20220035882A KR20220035882A KR1020220021991A KR20220021991A KR20220035882A KR 20220035882 A KR20220035882 A KR 20220035882A KR 1020220021991 A KR1020220021991 A KR 1020220021991A KR 20220021991 A KR20220021991 A KR 20220021991A KR 20220035882 A KR20220035882 A KR 20220035882A
- Authority
- KR
- South Korea
- Prior art keywords
- nodules
- biomarker
- benign tumors
- distinguishing cancer
- distinguishing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020220021991A KR102540673B1 (en) | 2020-09-14 | 2022-02-21 | Biomarker for distinguishing cancer from benign tumors or nodules |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200117956A KR102461422B1 (en) | 2020-09-14 | 2020-09-14 | Biomarker for distinguishing cancer from benign tumors or nodules |
| KR1020220021991A KR102540673B1 (en) | 2020-09-14 | 2022-02-21 | Biomarker for distinguishing cancer from benign tumors or nodules |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200117956A Division KR102461422B1 (en) | 2020-09-14 | 2020-09-14 | Biomarker for distinguishing cancer from benign tumors or nodules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20220035882A true KR20220035882A (en) | 2022-03-22 |
| KR102540673B1 KR102540673B1 (en) | 2023-06-08 |
Family
ID=80988848
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200117956A KR102461422B1 (en) | 2020-09-14 | 2020-09-14 | Biomarker for distinguishing cancer from benign tumors or nodules |
| KR1020220021991A KR102540673B1 (en) | 2020-09-14 | 2022-02-21 | Biomarker for distinguishing cancer from benign tumors or nodules |
| KR1020220021988A KR102540668B1 (en) | 2020-09-14 | 2022-02-21 | Biomarker for distinguishing cancer from benign tumors or nodules |
| KR1020220118406A KR102643326B1 (en) | 2020-09-14 | 2022-09-20 | Biomarker for distinguishing cancer from benign tumors or nodules |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200117956A KR102461422B1 (en) | 2020-09-14 | 2020-09-14 | Biomarker for distinguishing cancer from benign tumors or nodules |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020220021988A KR102540668B1 (en) | 2020-09-14 | 2022-02-21 | Biomarker for distinguishing cancer from benign tumors or nodules |
| KR1020220118406A KR102643326B1 (en) | 2020-09-14 | 2022-09-20 | Biomarker for distinguishing cancer from benign tumors or nodules |
Country Status (1)
| Country | Link |
|---|---|
| KR (4) | KR102461422B1 (en) |
-
2020
- 2020-09-14 KR KR1020200117956A patent/KR102461422B1/en active IP Right Grant
-
2022
- 2022-02-21 KR KR1020220021991A patent/KR102540673B1/en active IP Right Grant
- 2022-02-21 KR KR1020220021988A patent/KR102540668B1/en active IP Right Grant
- 2022-09-20 KR KR1020220118406A patent/KR102643326B1/en active IP Right Grant
Non-Patent Citations (3)
| Title |
|---|
| Clin Exp Pharmacol Physiol, 47(4): 696-702 (2020.01.22.)* * |
| Int J Mol Sci, 18(6): 1184 (2017.06.02.)* * |
| Med Sci Monit, 25: 9752-9769 (2019.12.19.)* * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220133832A (en) | 2022-10-05 |
| KR20220035881A (en) | 2022-03-22 |
| KR102540673B1 (en) | 2023-06-08 |
| KR20220035790A (en) | 2022-03-22 |
| KR102643326B1 (en) | 2024-03-05 |
| KR102540668B1 (en) | 2023-06-08 |
| KR102461422B1 (en) | 2022-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180698T1 (en) | Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) | |
| GB201808476D0 (en) | Biomarkers for colorectal cancer | |
| NZ746554A (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| WO2014144657A3 (en) | Compositions and methods for cancer prognosis | |
| IL285218A (en) | Biomarkers for diagnosing ovarian cancer | |
| WO2009108917A3 (en) | Markers for improved detection of breast cancer | |
| IL290363A (en) | Ripretinib for treating gastrointestinal stromal tumors | |
| GB201919219D0 (en) | Cancer biomarkers | |
| EP4034084A4 (en) | Compositions and methods for treating metastatic gastrointestinal cancer | |
| IL289348A (en) | Novel diagnostic marker for pancreatic cancer | |
| EP3861348A4 (en) | Biomarker combinations for determining aggressive prostate cancer | |
| KR20220035882A (en) | Biomarker for distinguishing cancer from benign tumors or nodules | |
| EP3969001A4 (en) | Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating notch-activated breast cancer | |
| EP3962919A4 (en) | Compounds for treating cancer | |
| GB201915464D0 (en) | Novel biomarkers and diagnostic profiles for prostate cancer | |
| GB201909468D0 (en) | Compounds for treating cancer | |
| GB202103080D0 (en) | Cancer biomarkers | |
| GB2594103B (en) | Prostate cancer biomarkers | |
| EP4083627A4 (en) | Prognostic biomarker of cancer | |
| MX2015011589A (en) | Cabazitaxel and its use for treating metastatic prostate cancers. | |
| EP4146274A4 (en) | Methods for treating pancreatic cancer and other solid tumors | |
| EP4010490A4 (en) | Molecular classifiers for prostate cancer | |
| IL307858A (en) | Biomarkers for colorectal cancer | |
| GB202020493D0 (en) | Cancer biomarkers | |
| GB202315205D0 (en) | Biomarkers for prostate cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| E902 | Notification of reason for refusal | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |